Found 9 matching trials
ATORvastatin in Pulmonary TUBerculosis
PHASE2Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Location
National Tuberculosis Reference Laboratory
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
PHASE4Many trials suggested that lipid lowering therapy could significantly reduc...
Location
The Second Affiliated Hospital of Harbin Medical University
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
PHASE2The purpose of this study is to assess pharmacokinetic parameters of atorva...
Location
National Tuberculosis and Leprosy Training Centre, Saye
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
PHASE1This study aims first to assess the efficacy, safety, and effectiveness of ...
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
PHASE4The purpose of this study is to determine whether HMG-CoA reductase inhibit...
Location
National Defense medical College
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
PHASE1The purpose of this study is to identify subjects who are highly sensitized...
Location
The University of Chicago
A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers
PHASE1To evaluate the influence of BR1017-1 and BR1017-2 on pharmacokinetics and ...
Location
CHA Bundang Medical Center, CHA University
A Study of LY3478045 in Healthy Participants
PHASE1The main purpose of this study in healthy participants is to learn more abo...
Endovascular Treatment and RIPC in Acute Ischemic Stroke
NAEndovascular treatment(ET)is an effective therapy for acute ischemic stroke...
Location
First Affiliated Hospital of Xi'an Jiaotong University